002880 Share Price Performance
CN¥0
-27.74 (-100.00%)
Price CN¥0
Share Pricen/a
Shenzhen Weiguang Biological Products Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
002880 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Shenzhen Weiguang Biological Products Co., Ltd. Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 27, 2026
- 1.01
- 42.38%
- 20.06%
- 28.5%
About 002880
- Founded
- 1985
- Employees
- 859
- CEO
- WebsiteView website
Shenzhen Weiguang Biological Products Co., Ltd. primarily engages in the research, development, production, and sale of blood products in China. The company offers human factor VIII, human immunoglobulin (PH4), human rabies immunoglobulin, human tetanus immunoglobulin, human hepatitis B immunoglobulin, human albumin, human histaglobulin, human firbrinogen, human immunoglobulin for intravenous injection freeze-dried, lyophilized human rabies vaccine and human prothrombin complex. Shenzhen Weiguang Biological Products Co., Ltd. was founded in 1985 and is based in Shenzhen, China.
